Patent crunch pending

Drug makers are fighting a rear-guard action against patent laws that are before the US Congress. Meredith Wadman reports.

"You shouldn't have to throw the biotech industry under a bus to make life easier for the IT industry." ? Jim Greenwood Credit: C. CORDER/NEWSCOM

Makers of insulin inhalers fear that their patents will be devalued.